These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16936982)

  • 1. [Thyroglobulin mRNA amplification in peripheral blood of patients with differentiated thyroid carcinoma: what does it really mean?].
    Coelho SM; Vaisman M; de Carvalho DP
    Arq Bras Endocrinol Metabol; 2006 Jun; 50(3):427-35. PubMed ID: 16936982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
    Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of papillary thyroid cancer suspected by high anti-thyroglobulin antibody levels and detection of peripheral blood thyroglobulin mRNA.
    Coelho SM; Buescu A; Corbo R; Carvalho DP; Vaisman M
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1321-5. PubMed ID: 19169488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.
    Pellegriti G; Scollo C; Regalbuto C; Attard M; Marozzi P; Vermiglio F; Violi MA; Cianci M; Vigneri R; Pezzino V; Squatrito S
    Clin Endocrinol (Oxf); 2003 May; 58(5):556-61. PubMed ID: 12699436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
    Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
    Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancer.
    Eszlinger M; Neumann S; Otto L; Paschke R
    Eur J Endocrinol; 2002 Nov; 147(5):575-82. PubMed ID: 12444888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer.
    Grammatopoulos D; Elliott Y; Smith SC; Brown I; Grieve RJ; Hillhouse EW; Levine MA; Ringel MD
    Mol Pathol; 2003 Jun; 56(3):162-6. PubMed ID: 12782763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroglobulin: current status in differentiated thyroid carcinoma (review).
    Harish K
    Endocr Regul; 2006 Jun; 40(2):53-67. PubMed ID: 17100547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.
    Elisei R; Vivaldi A; Agate L; Molinaro E; Nencetti C; Grasso L; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):33-9. PubMed ID: 14715824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
    Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
    Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
    Biscontini G; Possa M; Sara R; Milella M; Rossetti C
    Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
    Kaufmann S; Schmutzler C; Schomburg L; Körber C; Luster M; Rendl J; Reiners C; Köhrle J
    Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.
    Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
    Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
    Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
    Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
    Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thyroglobulin in the monitoring of differentiated thyroid cancer.
    Evans C; Tennant S; Perros P
    Scand J Clin Lab Invest Suppl; 2016; 245():S119-23. PubMed ID: 27542000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
    Golger A; Fridman TR; Eski S; Witterick IJ; Freeman JL; Walfish PG
    J Endocrinol Invest; 2003 Oct; 26(10):1023-31. PubMed ID: 14759077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.
    Ringel MD; Ladenson PW; Levine MA
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4435-42. PubMed ID: 9851791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.